243 related articles for article (PubMed ID: 14976782)
21. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
Ma H; Zhuang X
Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
[TBL] [Abstract][Full Text] [Related]
23. A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia.
Pendeville PE; Lois F; Scholtes JL
Eur J Anaesthesiol; 2007 Jun; 24(6):546-50. PubMed ID: 17241507
[TBL] [Abstract][Full Text] [Related]
24. [The time-course of action of rapacuronium and mivacurium after early reversal following equally lasting relaxation].
Geldner G; Lang C; Hoffmann W; Hossfeld A; Weinberger J; Eble M; Blobner M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):594-9. PubMed ID: 12975739
[TBL] [Abstract][Full Text] [Related]
25. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
Kansanaho M; Olkkola KT
Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
[TBL] [Abstract][Full Text] [Related]
26. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
[TBL] [Abstract][Full Text] [Related]
27. No substitute for the intravenous route.
Donati F; Guay J
Anesthesiology; 2001 Jan; 94(1):1-2. PubMed ID: 11135714
[No Abstract] [Full Text] [Related]
28. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
29. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination.
Naguib M
Anesthesiology; 1994 Aug; 81(2):388-95. PubMed ID: 8053589
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
Atherton DP; Hunter JM
Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
[TBL] [Abstract][Full Text] [Related]
31. Comparison of suxamethonium and different combinations of rocuronium and mivacurium for rapid tracheal intubation in children.
Naguib M; Samarkandi AH; Ammar A; Turkistani A
Br J Anaesth; 1997 Oct; 79(4):450-5. PubMed ID: 9389261
[TBL] [Abstract][Full Text] [Related]
32. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
33. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
Han T; Kim H; Bae J; Kim K; Martyn JA
Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
[TBL] [Abstract][Full Text] [Related]
34. Priming with rocuronium accelerates neuromuscular block in children: a prospective randomized study.
Bock M; Haselmann L; Böttiger BW; Motsch J
Can J Anaesth; 2007 Jul; 54(7):538-43. PubMed ID: 17602039
[TBL] [Abstract][Full Text] [Related]
35. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium.
Adamus M; Gabrhelik T; Marek O
Eur J Anaesthesiol; 2008 Jul; 25(7):589-95. PubMed ID: 18405411
[TBL] [Abstract][Full Text] [Related]
36. Muscle relaxants: a clinical update.
Buzello W; Diefenbach C; Nigrovic V
Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
[TBL] [Abstract][Full Text] [Related]
37. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
[TBL] [Abstract][Full Text] [Related]
38. Use of intermediate acting muscle relaxants by infusion: the future.
Mirakhur RK; McCourt KC; Kumar N
Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
[TBL] [Abstract][Full Text] [Related]
39. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
Kendrick DB; Monroe KW; Bernard DW; Tofil NM
Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
[TBL] [Abstract][Full Text] [Related]
40. A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
Vanacker BF; Geerts E; Coppens S; van Iersel M
Anesth Analg; 2002 Apr; 94(4):876-8, table of contents. PubMed ID: 11916789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
